Joseph C. Galante, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 1,441 shares at $2.17 ($3K) on 2022-05-24, disclosed to the SEC on 2022-06-10.
Scheduled purchase ($3k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.45 | 61 | $149 | 4.5% |
| 2 | $2.42 | 61 | $148 | 4.5% |
| 3 | $2.37 | 61 | $145 | 4.4% |
| 4 | $2.35 | 61 | $143 | 4.3% |
| 5 | $2.36 | 61 | $144 | 4.3% |
| 6 | $2.63 | 68 |
| $179 |
| 5.4% |
| 7 | $2.55 | 68 | $173 | 5.2% |
| 8 | $2.37 | 68 | $161 | 4.9% |
| 9 | $2.23 | 68 | $152 | 4.6% |
| 10 | $2.32 | 68 | $158 | 4.8% |
| 11 | $2.31 | 68 | $157 | 4.7% |
| 12 | $2.35 | 68 | $160 | 4.8% |
| 13 | $2.31 | 68 | $157 | 4.7% |
| 14 | $2.29 | 68 | $156 | 4.7% |
| 15 | $2.23 | 68 | $152 | 4.6% |
| 16 | $2.17 | 76 | $165 | 5.0% |
| 17 | $2.17 | 76 | $165 | 5.0% |
| 18 | $2.15 | 76 | $163 | 4.9% |
| 19 | $2.12 | 76 | $161 | 4.9% |
| 20 | $2.13 | 76 | $162 | 4.9% |
| 21 | $2.13 | 76 | $162 | 4.9% |
| Total | $2.30 avg | 1,441 | $3K | 100% |
| Filing → |
| CPIX | BUY | 2022-12-23 | $3K | — | Filing → |
| CPIX | BUY | 2022-11-18 | $4K | — | Filing → |
| CPIX | BUY | 2022-09-30 | $5K | — | Filing → |